Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT). Results of a Phase 2 Trial

Gerald A. Soff, MD, Yimei Miao, BS, Sean M. Devlin, PhD, Simon Mantha, MD MPH, Jodi V Mones, MD, Valery J Li, MD, Ghassan K Abou-Alfa, MD MBA, Andrea Cercek, MD, Nancy Kemeny, MD, Rekha Parameswaran, MD

Blood (2017) 130 (Supplement 1): 289.

https://doi.org/10.1182/blood.V130.Suppl_1.289.289

Published: 2017

Journal Articles

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Treatment of Cancer-Associated Thrombosis

Aaron P Soff, Judy Dong, MD, Simon Mantha, MD MPH, Gerald A. Soff, MD

Blood (2016) 128 (22): 2619.

https://doi.org/10.1182/blood.V128.22.2619.2619

Published: 2016

Journal Articles

Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer

Eva Simona Laube, MD, Anthony Yu, MD, Dipti Gupta, MD MPH, Yimei Miao, BS, Patrick Samedy, MS, Jonathan Wills, BA, Stephen J. Harnicar, PharmD, BCOP, BCPS, Gerald A. Soff, MD, Simon Mantha, MD MPH

Blood (2016) 128 (22): 2621.

https://doi.org/10.1182/blood.V128.22.2621.2621

Published: 2016

Journal Articles

Outcomes of Inferior Vena Cava Filter Placement in a Large Population of Cancer Patients Diagnosed with Pulmonary Embolism: Risk for Recurrent Venous Thromboembolism, Survival, and Filter-Related Complications

Catherine C. Coombs, MD, Deborah Kuk, ScM, Sean Devlin, PhD, Robert Siegelbaum, MD, Rekha Parameswaran, MD, Simon Mantha, MD MPH, Gerald A Soff, MD

Blood (2015) 126 (23): 1112.

https://doi.org/10.1182/blood.V126.23.1112.1112

Published: 2015

Journal Articles

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Thrombosis

Aaron P Soff, Judy Dong, MD, Aiqi Dong, Sean Devlin, PhD, Simon Mantha, MD MPH, Rekha Parameswaran, MD, Gerald A Soff, MD

Blood (2015) 126 (23): 2068.

https://doi.org/10.1182/blood.V126.23.2068.2068

Published: 2015

Journal Articles

Safe and Effective Use of Rivaroxaban for Treatment of Cancer-Associated Venous Thromboembolic Disease: A Quality Improvement Initiative

Simon Mantha, MD MPH, Yimei Miao, BS, Debra Sarasohn, MD, Jonathan Kessler, Rekha Parameswaran, MD, Samantha Stefanik, Gagandeep Brar, MD, Patrick Samedy, Jonathan Wills, Dhruvkumar Patel, Gerald A Soff, MD

Blood (2015) 126 (23): 431.

https://doi.org/10.1182/blood.V126.23.431.431

Published: 2015

Journal Articles

Enoxaparin Dose Reduction for Thrombocytopenia in Patients with Cancer: A Quality Assessment Study

Yimei Miao, BS, Gerald A Soff, MD, Rekha Parameswaran, MD, Jonathan Wills, Simon Mantha, MD MPH

Blood (2015) 126 (23): 429.

https://doi.org/10.1182/blood.V126.23.429.429

Published: 2015

Journal Articles

MLL Exons 4-8 Duplication in a Patient with Calr -Mutated Essential Thrombocythemia

Simon Mantha, MD MPH, Ross L. Levine, MD, Raajit K. Rampal, MD PhD

Blood (2014) 124 (21): 5583.

https://doi.org/10.1182/blood.V124.21.5583.5583

Published: 2014

Journal Articles

Determinants of Fatal Bleeding during Induction Therapy for Acute Promyelocytic Leukemia in the ATRA Era

Simon Mantha, MD MPH, Debra Goldman, MS, Sean M. Devlin, PhD, Ju-Whei Lee, PhD, Diana Zannino, BSc, MSc, Dan Douer, MD, Harry J Iland, MBBS FRACP FRCPA, Mark R. Litzow, MD, Eytan M. Stein, Frederick Appelbaum, MD, Richard A. Larson, Jacob M. Rowe, MD, Martin S. Tallman, MD

Blood (2014) 124 (21): 948.

https://doi.org/10.1182/blood.V124.21.948.948

Published: 2014

Journal Articles

Predicting INR Time In The Therapeutic Range: A Bayesian Approach

Simon Mantha, MD, MPH, Adam Rose, MD, Stephan Moll, MD

Blood (2013) 122 (21): 2385.

https://doi.org/10.1182/blood.V122.21.2385.2385

Published: 2013

Journal Articles

Indirect Comparison Of Dabigatran, Rivaroxaban and Apixaban For Venous Thromboembolic Disease

Simon Mantha, MD, MPH, Jack Ansell, MD

Blood (2013) 122 (21): 3640.

https://doi.org/10.1182/blood.V122.21.3640.3640

Published: 2013

Journal Articles

Progestin-Only Contraceptives and the Risk of Venous Thromboembolism: Systematic Review and Meta-Analysis,

Simon Mantha, MD, MPH, Vidya Raghavan, MD, MB, BS, Rebecca Karp, MD, Norma Terrin, PhD, Kenneth A. Bauer, MD, Jeffrey Zwicker, MD

Blood (2011) 118 (21): 3344.

https://doi.org/10.1182/blood.V118.21.3344.3344

Published: 2011

NARROW

Romiplostim for Chemotherapy-Induced Thrombocytopenia (CIT). Results of a Phase 2 Trial

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Treatment of Cancer-Associated Thrombosis

Rivaroxaban for Stroke Prevention in Patients with Non-Valvular Atrial Fibrillation and Active Cancer

Outcomes of Inferior Vena Cava Filter Placement in a Large Population of Cancer Patients Diagnosed with Pulmonary Embolism: Risk for Recurrent Venous Thromboembolism, Survival, and Filter-Related Complications

Reduced Emergency Room Utilization for Initiation of Anticoagulation with Rivaroxaban Versus Low Molecular Weight Heparin for Treatment of Cancer-Associated Thrombosis

Safe and Effective Use of Rivaroxaban for Treatment of Cancer-Associated Venous Thromboembolic Disease: A Quality Improvement Initiative

Enoxaparin Dose Reduction for Thrombocytopenia in Patients with Cancer: A Quality Assessment Study

MLL Exons 4-8 Duplication in a Patient with Calr -Mutated Essential Thrombocythemia

Determinants of Fatal Bleeding during Induction Therapy for Acute Promyelocytic Leukemia in the ATRA Era

Predicting INR Time In The Therapeutic Range: A Bayesian Approach

Indirect Comparison Of Dabigatran, Rivaroxaban and Apixaban For Venous Thromboembolic Disease

Progestin-Only Contraceptives and the Risk of Venous Thromboembolism: Systematic Review and Meta-Analysis,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only